Literature DB >> 16135740

Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.

W-J Koh, O J Kwon, Y K Park, W J Lew, G H Bai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16135740     DOI： 10.1183/09031936.05.00045605

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results.

Authors:  Joon-Sung Joh; Chang Hoon Lee; Ji Eun Lee; Young-Kil Park; Gill-Han Bai; Eui-Chong Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

2.  Treatment of isoniazid-resistant pulmonary tuberculosis.

Authors:  Yee Hyung Kim; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Seong Yong Lim; Si Young Lim; Won-Jung Koh
Journal:  BMC Infect Dis       Date:  2008-01-23       Impact factor: 3.090

Review 3.  Treatment of Isoniazid-Resistant Pulmonary Tuberculosis.

Authors:  Byung Woo Jhun; Won Jung Koh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2020-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.